Sung Yong Gyu, Yoon Hyukjin, Park Dong Chul, Kim Man Soo, In Yong
Department of Orthopaedic Surgery, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Division of Nuclear Medicine, Department of Radiology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon-si, Republic of Korea.
Orthop J Sports Med. 2022 Oct 12;10(10):23259671221121083. doi: 10.1177/23259671221121083. eCollection 2022 Oct.
Qualitative studies have explored changes in Tc-99m hydroxymethylene diphosphonate (HDP) uptake on single-photon emission computed tomography and computed tomography (SPECT/CT) as a result of offloading after medial opening-wedge high tibial osteotomy (MOWHTO) in patients with medial compartment knee osteoarthritis. However, whether changes in the Tc-99m HDP uptake on SPECT/CT reflect the degree of clinical improvement in postoperative outcomes, especially when using minimal clinically important differences (MCIDs), has not been investigated.
To investigate the association between changes in Tc-99m HDP uptake on SPECT/CT and MCID-based improvement on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score in patients who underwent MOWHTO.
Cross-sectional study; Level of evidence, 3.
The study included 35 knees in 31 patients who underwent MOWHTO. SPECT/CT was performed preoperatively and 3 years postoperatively with clinical and radiological assessments. On SPECT/CT, the knee joint was divided into 10 regions, and the radiotracer uptake amount of each region was divided by the uptake amount of the reference zone. Patients were divided into 2 groups based on whether they achieved the MCID of 16.1 points on the WOMAC at 3 years postoperatively, and changes in uptake amount on SPECT/CT were compared between the groups.
At 3 years postoperatively, 22 patients achieved the MCID on the WOMAC (62.9%; above-MCID group) and 13 patients did not (37.1%; below-MCID group). In the above-MCID group, significant improvement was observed in the WOMAC after MOWHTO (from 55.8 to 19.6; < .05); however, significant improvement was not observed in the below-MCID group (from 38.8 to 32.3; = .100). Based on mean change of uptake on SPECT/CT in each region, the above-MCID group showed significantly greater reduction of uptake on SPECT/CT than the below-MCID group in the femoral anteromedial compartment ( = .004), tibial anteromedial compartment ( = .009), and tibial anterolateral compartment ( = .031).
Reduction in radiotracer uptake on SPECT/CT of the knee joint reflected clinical improvement in patient-reported outcomes following MOWHTO.
定性研究探讨了内侧间室膝关节骨关节炎患者行内侧开口楔形高位胫骨截骨术(MOWHTO)后负重减轻导致的锝-99m亚甲基二膦酸盐(HDP)在单光子发射计算机断层扫描和计算机断层扫描(SPECT/CT)上摄取的变化。然而,SPECT/CT上锝-99m HDP摄取的变化是否反映术后临床改善程度,尤其是使用最小临床重要差异(MCID)时,尚未得到研究。
研究接受MOWHTO的患者SPECT/CT上锝-99m HDP摄取的变化与基于MCID的西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分改善之间的关联。
横断面研究;证据等级,3级。
本研究纳入31例行MOWHTO患者的35个膝关节。术前及术后3年进行SPECT/CT检查,并进行临床和影像学评估。在SPECT/CT上,将膝关节分为10个区域,每个区域的放射性示踪剂摄取量除以参考区的摄取量。根据术后3年WOMAC评分是否达到16.1分的MCID将患者分为两组,并比较两组SPECT/CT上摄取量的变化。
术后3年,22例患者WOMAC评分达到MCID(62.9%;MCID以上组),13例患者未达到(37.1%;MCID以下组)。在MCID以上组,MOWHTO后WOMAC评分有显著改善(从55.8降至19.6;P<0.05);然而,MCID以下组未观察到显著改善(从38.8降至32.3;P=0.100)。根据每个区域SPECT/CT摄取的平均变化,MCID以上组在股骨前内侧间室(P=0.004)、胫骨前内侧间室(P=0.009)和胫骨前外侧间室(P=0.031)的SPECT/CT摄取减少显著大于MCID以下组。
膝关节SPECT/CT上放射性示踪剂摄取的减少反映了MOWHTO后患者报告结局的临床改善。